0001055726-19-000044.txt : 20190523
0001055726-19-000044.hdr.sgml : 20190523
20190523162135
ACCESSION NUMBER: 0001055726-19-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190521
FILED AS OF DATE: 20190523
DATE AS OF CHANGE: 20190523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Jong Joseph
CENTRAL INDEX KEY: 0001464549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 19850368
MAIL ADDRESS:
STREET 1: 660 W. GERMANTOWN PIKE
STREET 2: SUITE 110
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_155864288064924.xml
FORM 4
X0306
4
2019-05-21
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001464549
Kim Jong Joseph
660 W. GERMANTOWN PIKE SUITE 110
PLYMOUTH MEETING
PA
19462
1
1
0
0
Chief Executive Officer
Common Stock
2019-05-21
4
S
0
100000
3.31
D
2411055
D
Common Stock
1613232
I
By Family Limited Partnership
Common Stock
33563
I
By Daughter: EK
Common Stock
33775
I
By Son: JK1
Common Stock
5975
I
By Spouse
Common Stock
33533
I
By Son: JK2
The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan.
These transactions were executed in multiple trades at prices ranging from $3.30 to $3.33, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
/s/ Jong Joseph Kim
2019-05-23